Labocanna S.A. (WSE: LCN)
Health Care · Pharmaceuticals · PL
zł0.22
+4.67% today · -15.2% 1Y
Labocanna S.A. (WSE: LCN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.21M.
Over the last twelve months the share price has lost 15.2%, trading between 0.18 and 0.27.
Tweenvest scores Labocanna S.A. across four factors: quality 51/100, value 41/100, growth 100/100. Its strongest factor is growth.
LCN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.21M
- Revenue (TTM)
- $688.53K
- P/E
- —
- EPS
- -0.17
- Dividend yield
- —
- Beta (5Y)
- 0.63
- 52-week high
- zł0.27
- 52-week low
- zł0.18
- Avg volume (3M)
- —
- Shares outstanding
- 21.20M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Akanda Corp.NasdaqCM: AKAN | $1.38M | $1.76 | -11.11% |
| Beryl Drugs LimitedBSE: 524606 | $1.38M | Rs26.31 | +4.03% |
| CBD Life Sciences Inc.OTCPK: CBDL | $1.27M | $0.00 | +100.00% |
| Nascent Pharma Holdings, Inc.OTCPK: NASC | $1.25M | $0.01 | -4.60% |
| Emmessar Biotech & Nutrition LimitedBSE: 524768 | $1.17M | Rs22.59 | -1.74% |
| Silo Wellness Inc.CNSX: SILO | $1.14M | CA$— | — |
| Kobo Biotech LimitedBSE: 531541 | $1.13M | Rs4.59 | +26.80% |
| GelStat CorporationOTCPK: GSAC | $1.12M | $0.00 | +25.00% |
Figures last refreshed Oct 11, 2026.